Regional efficacy assessment in multiregional clinical development

Area of Science:

• Clinical trial methodology
• Pharmaceutical development
• Regulatory science

Background:

• Multiregional clinical trials often combine global and local data for regulatory submissions.
• Efficient drug development necessitates integrating data from diverse geographical regions.
• Combining global and local trial data for local regulatory filings presents significant challenges.

Purpose of the Study:

• To propose a novel evaluation criterion for combining global and local clinical trial data.
• To develop a method for unbiased estimation of treatment effects in multiregional drug development.
• To facilitate discussions with regulatory agencies regarding data integration.

Main Methods:

• An "interpretation-centric" evaluation criterion using a weighted estimator.
• Weighting data from the target country and outside the target country.
• Determining sample size for local trials using the weighted estimator.

Main Results:

• The proposed weighted estimator provides an unbiased estimate of the global treatment effect.
• The method ensures appropriate representation of the target country's patient population.
• The approach facilitates drug development discussions with local regulatory agencies.

Conclusions:

• The weighted estimator offers a robust solution for integrating global and local trial data.
• This approach enhances the efficiency and validity of drug development for local markets.
• The methodology supports sample size determination for local trials and regulatory interactions.